戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 , very low density lipoprotein remnants, and intermediate-density lipoprotein.
2 oteins) and significantly increased VLDL and intermediate density lipoproteins.
3 triacylglycerol (24%), large VLDL (92%), and intermediate-density lipoproteins (53%) and the mean dia
4 iglyceridemia and elevated concentrations of intermediate density lipoproteins and HDL.
5 sterol, HDL cholesterol, apolipoprotein A-I, intermediate-density lipoprotein and large LDL particles
6                                Reductions in intermediate-density lipoprotein and LDL production also
7  lipoproteins (very low density lipoprotein, intermediate density lipoprotein, and low density lipopr
8 and phospholipid concentrations in the VLDL, intermediate-density lipoprotein, and LDL (P < 0.05-0.01
9 VLDL-apoB (P<0.001 and P.032, respectively), intermediate-density lipoprotein-apoB (P=0.021 and P=.00
10 torvastatin decreased the production rate of intermediate-density lipoprotein-apoB (P=0.043) and LDL-
11 oprotein (VLDL)-apolipoprotein B-100 (apoB), intermediate-density lipoprotein-apoB, and LDL-apoB in 8
12 lesterol; LDL particle count, small LDL, and intermediate-density lipoprotein by nuclear magnetic res
13  beta-arrestin2 increased total and LDL plus intermediate-density lipoprotein cholesterol levels by 2
14  pattern of LDL, lipoprotein(a) cholesterol, intermediate-density lipoprotein cholesterol, high-densi
15  levels and greater cholesterol in VLDLs and intermediate-density lipoproteins compared with subjects
16 ass concentrations of the highly atherogenic intermediate-density lipoprotein fraction in patients wi
17  any carotenoid was found in the VLDL + IDL (intermediate-density-lipoprotein) fractions.
18 poprotein B (apoB)-100- and apoB-48-carrying intermediate density lipoproteins (IDL) and low density
19  in very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL)) progressively a
20                                              Intermediate density lipoproteins (IDL)+LDL increased mo
21  of very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL).
22 vels increase as a result of accumulation of intermediate-density lipoprotein (IDL) comprising VLDL a
23 y effects on very low-density lipoprotein or intermediate-density lipoprotein (IDL) metabolism.
24 e cholesterol content was increased in VLDL, intermediate-density lipoprotein (IDL), and dense LDL fr
25                               Multiple VLDL, intermediate-density lipoprotein (IDL), and LDL fraction
26 o induced a decreasing trend in serum total, intermediate-density lipoprotein (IDL), and low-density
27 evels in very low-density lipoprotein (VLDL)/intermediate-density lipoprotein (IDL).
28  Human fibroblasts were incubated with model intermediate-density lipoprotein- (IDL-) sized TGRP (10-
29 ow-density-lipoproteins (VLDL) subfractions, intermediate-density lipoproteins (IDLs), and low-densit
30 hospholipids were elevated in the endogenous intermediate density lipoprotein/LDL of double KO mice a
31 he Pon3KO had significantly increased plasma intermediate-density lipoprotein/LDL cholesterol and bil
32 ceride-rich very low density lipoprotein and intermediate density lipoprotein (lipoprotein B complex)
33                                              Intermediate-density lipoproteins, low-density lipoprote
34 Atherogenic very low density lipoprotein and intermediate density lipoprotein/low density lipoprotein
35 led increased triglyceride concentrations in intermediate density lipoprotein/low density lipoprotein
36 s accounted for by a marked reduction in the intermediate density lipoprotein/low density lipoprotein
37 vely modified form of cholesterol, in plasma intermediate density lipoprotein/low-density lipoprotein
38  of large HDLNMR particles and total IDLNMR (intermediate-density lipoprotein) particles in subjects
39 duction in very low density lipoproteins and intermediate density lipoproteins, respectively.
40 g their origin from low-density lipoprotein, intermediate-density lipoprotein, very-low-density lipop
41 m of autologous (125)I-apoB very low density/intermediate density lipoprotein (VLDL/IDL) (fractional
42  the mAb reacted with intact human very-low-/intermediate-density lipoprotein (VLDL/IDL) and low-dens

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。